Last reviewed · How we verify
A Randomized, Evaluator-blinded, Comparative Study to Evaluate the Efficacy and Safety of Different Injection Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines
A randomized, evaluator-blinded, comparative, study to evaluate the efficacy and safety of different injection volumes of botulinum toxin type A, Azzalure, in the glabellar lines.
Details
| Lead sponsor | Galderma R&D |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 62 |
| Start date | 2014-04 |
| Completion | 2014-12 |
Conditions
- Glabellar Frown Lines
Interventions
- Azzalure
Primary outcomes
- Assessment of severity of glabellar lines at rest and at maximum frown using the Merz Aesthetic 5-point scale. (However no primary outcome measure is defined in the study protocol) — Month 1
To evaluate effect on glabellar line severity
Countries
Sweden